- ►jcojournal.org OA O'Connor, J Wright, C Moskowitz, J Muzzy, … - Journal of Clinical Oncology, 2005 - jcojournal.org PATIENTS AND METHODS: Patients with indolent and MCL were eligible. Bortezomib
was given at a dose of 1.5 mg/m 2 on days 1, 4, 8, and 11. Patients were
required to have received no more than three prior chemotherapy regimens, ... Cited by 278 - Related articles - All 8 versions
G Socié, N Salooja, A Cohen, A Rovelli, E … - Blood, 2003 - Am Soc Hematology Large numbers of patients now survive long term following stem cell
transplantation (SCT). The late clinical effects of SCT are thus of major
concern in the 21st century. Secondary malignant diseases are of particular ... Cited by 122 - Related articles - BL Direct - All 8 versions
- ►hematologylibrary.org L Ades, JY Mary, M Robin, C Ferry, R Porcher … - Blood, 2004 - bloodjournal.hematologylibrary.org From January 1978 to December 2001, 133 patients with severe aplastic anemia
(SAA) underwent non-T cell-depleted allogeneic bone marrow transplantation from
an HLA-identical sibling donor, at the Hospital Saint Louis using either ... Cited by 109 - Related articles - BL Direct - All 8 versions
- ►jcojournal.org KS Baker, TE DeFor, LJ Burns, NKC Ramsay, … - Journal of Clinical Oncology, 2003 - jcojournal.org Results: Excluding nonmelanoma skin cancers (n = 19) and carcinoma-in-situ (n =
5), the remaining 123 cases represented an 8.1-fold (95% confidence interval
[CI], 6.7 to 9.6) increased risk of a PTM, an excess risk of 102.7 ... Cited by 107 - Related articles - BL Direct - All 7 versions
- ►jcojournal.org MA Andrykowski, MM Bishop, EA Hahn, DF … - Journal of clinical oncology, 2005 - jcojournal.org METHODS: HSCT survivors (n = 662) were recruited through the International Bone
Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry and
were drawn from 40 transplantation centers. HSCT survivors completed a ... Cited by 77 - Related articles - All 15 versions
L Tauchmanovà, C Selleri, MD Gennaro De … - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 58 - Related articles - BL Direct - All 5 versions
- ►hematologylibrary.org [PDF] RE Curtis, C Metayer, JD Rizzo, G Socie, KA … - Blood, 2005 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of 200,
Washington DC 20036. semimonthly by the American Society of Hematology, 1900 M
St, NW, Suite Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published Cited by 52 - Related articles - All 9 versions
- ►hematologylibrary.org RA Nash, PA McSweeney, LJ Crofford, M Abidi … - Blood, 2007 - bloodjournal.hematologylibrary.org More effective therapeutic strategies are required for patients with
poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose
immunosuppressive therapy (HDIT) and autologous CD34-selected hematopoietic ... Cited by 49 - Related articles - BL Direct - All 30 versions
- ►bloodjournal.org [PDF] A Egle, AW Harris, ML Bath, L O'Reilly, S Cory - Blood, 2003 - Am Soc Hematology Page 1. Targeting the Multidrug Resistance-1 Transporter in AML: Molecular Regulation
& Therapeutic Strategies. Daruka Mahadevan, MD, Ph.D. and Alan F. List, MD ... Cited by 41 - Related articles - BL Direct - All 9 versions
X Xiol, J Guardiola, S Menendez, C Lama, J … - Hepatology - interscience.wiley.com Liver transplant recipients are at greater risk for de novo neoplasia,
especially lymphoma and nonmelanoma skin cancer; however, risk factors for this
complication have not been well studied. Clinical and pathological records ... Cited by 39 - Related articles - BL Direct - All 4 versions
